Exploring the historical stigma of spironolactone use in breast cancer survivors with alopecia

Int J Womens Dermatol. 2023 Apr 18;9(2):e083. doi: 10.1097/JW9.0000000000000083. eCollection 2023 Jun.

Authors

Michael G Buontempo¹, Lina Alhanshali², Jerry Shapiro³, Kristen Lo Sicco³

Affiliations

¹ Department of Dermatology, Hackensack Meridian School of Medicine, Nutley, New Jersey.
² Department of Dermatology, SUNY Downstate College of Medicine, Brooklyn, New York.
³ The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, New York.

No abstract available

Keywords: alopecia; breast cancer; hair loss; spironolactone.

Publication types

Editorial